To get a GLP-1 prescription online in New York, you complete a health questionnaire, a New York-licensed clinician reviews it — usually by secure message, not a scheduled video call — and if they determine treatment is appropriate, a licensed pharmacy fills the prescription and ships it to your address. New York is one of the states where the entire process can happen asynchronously: no drive to a specialist, no waiting room, and for most patients, no video visit at all. See our state page for New York for current availability and pricing, or read on for exactly how the process works and what's specific to New York residents.
The short answer
New York allows a licensed clinician to establish care and prescribe a GLP-1 like semaglutide or tirzepatide entirely through an online intake and secure messaging — no video visit is required by state rule for non-controlled medications like these. The clinician reviewing your case must hold an active New York medical license; an out-of-state license isn't enough. Both compounded and FDA-approved brand-name GLP-1s are available through the same intake, and eligibility is always a clinical decision, never automatic.
How does the online intake work for New York residents?
The mechanics are the same questionnaire-then-review process used everywhere, but two details are New York-specific: who's allowed to review your case, and how nurse practitioners fit in.
- You complete an intake questionnaire. Medical history, current medications, prior GLP-1 use, and your goals — typically 5–10 minutes from a phone or computer.
- A New York-licensed clinician reviews it. New York requires any provider prescribing to a New York resident to hold an active New York medical license — a license from another state doesn't qualify, even for an otherwise identical telehealth visit. Nurse practitioners can also prescribe: under the Nurse Practitioner Modernization Act, an NP with more than 3,600 hours of practice experience can prescribe independently, with no physician agreement required; newer NPs prescribe under a written collaborative agreement with a physician.
- The clinician decides whether treatment is appropriate. This is a clinical judgment based on your history and goals, not a guarantee tied to submitting a form.
- A licensed pharmacy fills the prescription. Compounded preparations are prepared per-patient by a US-licensed compounding pharmacy; FDA-approved brand-name medications are filled by a licensed pharmacy that dispenses the commercially manufactured product.
- It ships to your New York address, typically within 2–3 business days of the pharmacy filling the order — whether you're in New York City or Long Island, or further upstate in Buffalo, Rochester, Syracuse, or Albany, the process and the price are the same.
For the full national walkthrough of each step — including what disqualifies someone and how to vet a provider — see how a GLP-1 prescription online actually works. This piece focuses on what changes when you're a New York resident.
Do I need a video visit in New York?
No. New York is one of the 43 async-first states, where the entire process — intake, clinician review, prescribing decision, and follow-up — can happen by secure message. Under New York Education Law and Department of Health telehealth guidance, a licensed provider may establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s through telehealth, including asynchronous, store-and-forward review of a completed intake, as long as the standard of care is met and informed consent is obtained. GLP-1s are not controlled substances, so New York's separate I-STOP and controlled-substance telemedicine requirements don't add friction here.
That said, "no video call required" isn't a promise that nothing will ever prompt one. Depending on your intake — a complex medical history, an unclear detail worth clarifying — a clinician may follow up by message, ask for a video visit, or request additional labs before prescribing. Most patients complete everything asynchronously, but the clinician's judgment about what your case needs comes first.
Check your eligibility in New York
Complete a short health questionnaire and a New York-licensed clinician will review whether a GLP-1 is appropriate for you — most patients never need to schedule a video call.
Start your intake →Compounded vs. brand-name GLP-1s in New York
Pallas offers both tiers to New York residents through the same intake, and they're worth telling apart:
- Compounded semaglutide and tirzepatide — including a microdose option and, for semaglutide, an oral tablet — prepared per-patient by US-licensed compounding pharmacies under FDCA §503A, prescribed when a New York-licensed clinician documents a patient-specific clinical rationale.
- FDA-approved brand-name medications — Wegovy® and Ozempic® (semaglutide, Novo Nordisk), Zepbound® and Mounjaro® (tirzepatide, Eli Lilly) — the same commercially manufactured products sold at any retail pharmacy, prescribed when a clinician determines they're appropriate. Brand-name prescriptions through Pallas are cash-pay only and are not billed to insurance.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.
Neither tier is "better" in the abstract — which one a clinician recommends depends on your history, goals, and what's clinically appropriate for you, and some patients move between tiers over time. What doesn't change between them is the review itself: both paths go through the same real clinician, licensed to prescribe in New York, before anything ships. For a deeper look at how the two compare nationally, see our compounded vs. brand-name GLP-1 guide; for tirzepatide specifically, see how to get tirzepatide online.
Does New York Medicaid cover GLP-1s?
It depends on the reason. New York Medicaid covers GLP-1s including Wegovy® for weight management, typically subject to step therapy and prior authorization — a broader benefit than some states offer. Compounded GLP-1s are not covered under any circumstance. Pallas is a cash-pay telehealth service — no insurance is billed for either tier — so this doesn't change how the intake or pricing works with us, but it's worth knowing if you were weighing the Medicaid route first. For current pricing, see what compounded semaglutide costs and the New York state page and New York cost page.
Is compounded semaglutide available in New York?
Yes — compounded semaglutide is available to eligible New York residents through licensed telehealth. It's prepared per-patient by a US-licensed compounding pharmacy under FDCA §503A, and a New York-licensed clinician must prescribe it based on a documented, patient-specific clinical rationale rather than cost or preference alone. FDA-approved brand-name options are available through the same intake if a compounded preparation isn't the right fit for you.
What should I check before choosing an online provider in New York?
The same red flags apply in New York as everywhere else, plus one New York-specific check:
- A New York medical license, verifiable. Ask, or check the New York State Education Department's license lookup. An out-of-state license doesn't satisfy New York's requirement, no matter how the provider markets itself.
- A real intake and clinician review — not just a payment form. If a site skips straight to checkout, it isn't practicing medicine in New York or anywhere else.
- A named, licensed pharmacy. A legitimate provider can tell you which pharmacy — retail or compounding — prepares and ships your medication.
- Verifiable LegitScript certification. LegitScript maintains a public database of certified healthcare merchants. Pallas is LegitScript Healthcare Merchant Certified, and you can look up any provider before paying.
The bottom line
New York residents can get a GLP-1 prescription online through a real clinical process: an intake questionnaire, review by a New York-licensed clinician (physician or NP), a prescribing decision based on your history, and fulfillment through a licensed pharmacy that ships to your address in a few business days. No video visit is required by state rule, both compounded and FDA-approved brand-name options are available, and New York Medicaid covers GLP-1s including Wegovy® for weight management (subject to step therapy and prior authorization) but not compounded preparations. Learn more about GLP-1 treatment at Pallas or start with the New York state page for current specifics.
Frequently asked questions
Start Pallas's online intake — it takes about 5 minutes and covers your health history, goals, and current medications. A New York-licensed clinician reviews it, and because New York allows asynchronous-first care for non-controlled medications like GLP-1s, that review can happen by secure message without a scheduled video call, unless your history calls for one — out-of-state licensure is never sufficient, so every clinician who treats you holds an active New York medical license. If a GLP-1 is clinically appropriate, your clinician prescribes it, and a US-licensed pharmacy ships your medication to any New York address within a few business days.
No — New York is asynchronous-first for non-controlled medications like GLP-1s. A New York-licensed clinician can review your intake by secure message and, if appropriate, prescribe semaglutide or tirzepatide without ever scheduling a video call, as long as the standard of care is met. A clinician may ask for a brief video visit or additional labs if your history calls for it, but most patients complete everything asynchronously.
Yes — compounded semaglutide is available to eligible New York residents through licensed telehealth. It's prepared per-patient by US-licensed compounding pharmacies under FDCA §503A, and a New York-licensed clinician must prescribe it based on a documented, patient-specific clinical rationale. FDA-approved brand-name options like Wegovy® and Zepbound® are also available through the same intake.
Several licensed telehealth platforms serve New York residents seeking compounded semaglutide. Before choosing one, verify that its clinicians are licensed in New York, that it works with US-licensed §503A compounding pharmacies, and that it holds LegitScript Healthcare Merchant Certification — you can check any platform's certification status in LegitScript's public database. Pallas serves New York residents and is LegitScript Healthcare Merchant Certified.
Yes. Under New York's Nurse Practitioner Modernization Act, an NP with more than 3,600 hours of practice experience can prescribe non-controlled medications like semaglutide and tirzepatide independently, with no physician agreement required; newer NPs prescribe under a written collaborative agreement with a physician. Because GLP-1s are not controlled substances, the full process can happen through telehealth, with no in-person visit required. Every Pallas clinician who treats New York patients holds an active New York license and prescribes within these rules.
It depends on the reason. New York Medicaid covers GLP-1s including Wegovy® for weight management, typically subject to step therapy and prior authorization, but compounded GLP-1s are not covered under any circumstance. Pallas is a cash-pay telehealth service, so this doesn't change your intake or pricing with us either way.
Yes. Telehealth intake, clinician review, and pharmacy fulfillment work the same whether you're in New York City, Long Island, Buffalo, Rochester, Syracuse, Albany, or a smaller upstate community — the online process doesn't vary by ZIP code, and neither does the price. What varies is only how quickly you complete your own intake, and shipping can run about a day longer in more rural upstate ZIP codes.
See if you qualify in New York
Pallas's intake is asynchronous for New York residents — complete it by message, and a New York-licensed clinician will let you know if a GLP-1 is appropriate for you. No insurance needed, cancel anytime.
Start your intake →Trademarks & disclosures
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Pallas is not affiliated with, endorsed by, or sponsored by either manufacturer. Brand-name GLP-1 medications dispensed through Pallas are cash-pay only and are not billed to insurance. Prescriptions — brand-name or compounded — are written only when a New York-licensed clinician determines treatment is appropriate.